JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

J Neurol Neurosurg Psychiatry. Published Online First: 9 May 2008. doi:10.1136/jnnp.2007.142174
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Hagenah, J. M
Right arrow Articles by Seidel, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagenah, J. M
Right arrow Articles by Seidel, G.

Short reports

Transcranial sonography findings in a large family with homo-and heterozygous PINK1 mutations

Johann M Hagenah 1*, Björn Becker 1, Norbert Brueggemann 1, Ana Djarmati 1, Katja Lohmann 1, Andreas Sprenger 1, Christine Klein 1 and Guenter Seidel 2

1 University of Luebeck, Germany
2 University of Schleswig-Holstein, Campus Lübeck, Germany

* To whom correspondence should be addressed. E-mail: johann.hagenah{at}neuro.uni-luebeck.de.

Accepted 7 April 2008


*  Abstract

Objective: To investigate substantia nigra (SN) echogenicity in members of a family with homozygous and heterozygous PINK1 mutations with or without signs of Parkinson’s disease (PD).

Methods: Transcranial sonography (TCS) was employed to investigate 20 members of a family with PINK1 mutations including four homozygous and eleven heterozygous mutation carriers and five individuals with no mutation. For comparison, a healthy control group of 18 subjects without a positive family history of PD (control group) and a healthy control group of 15 subjects with a positive family history of sporadic PD (relative group) were investigated. For statistical analysis, the larger area of the two SNs echogenicity (aSNmax) of each individual was selected.

Results: A significantly increased aSNmax was found for all subgroups compared to the control group. The group of homozygous carriers of a PINK1 mutation had a significantly increased aSNmax compared to all other subgroups, except the group of heterozygous mutation carriers.

Conclusions: Our findings in carriers of a PINK1 mutation are comparable to findings in carriers of Parkin mutations and nongenetic PD. The increased aSNmax in family members without a mutation suggests an additional contributing factor independent of the PINK1 mutation that may also play a role in relatives of sporadic PD patients.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.